morphine

(redirected from Embeda)
Also found in: Thesaurus, Medical, Encyclopedia.

mor·phine

 (môr′fēn′)
n.
An alkaloid, C17H19NO3, extracted from opium and used in the form of its hydrated sulfate or hydrochloride salt to relieve moderate to severe pain. Also called morphia.

[French, from Morphée, Morpheus, from Latin Morpheus.]

morphine

(ˈmɔːfiːn) or

morphia

n
(Pharmacology) an alkaloid extracted from opium: used in medicine as an analgesic and sedative, although repeated use causes addiction. Formula: C17H19NO3
[C19: from French, from Morpheus]

mor•phine

(ˈmɔr fin)

also mor•phi•a

(-fi ə)

n.
a white, bitter, crystalline alkaloid, C17H19NO3∙H2O, the most important narcotic and addictive principle of opium, obtained by extraction and crystallization and used chiefly in medicine as a pain reliever and sedative.
[1820–30; < German Morphin. See Morpheus, -ine2]
mor•phin′ic (-ˈfɪn ɪk) adj.

mor·phine

(môr′fēn′)
A drug extracted from opium, used in medicine to relieve severe pain and for its sedative effects. It can be highly addictive.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.morphine - an alkaloid narcotic drug extracted from opium; a powerful, habit-forming narcotic used to relieve pain
analgesic, anodyne, pain pill, painkiller - a medicine used to relieve pain
apomorphine - a morphine derivative that is not as strong as morphine; used as an emetic and in small doses as a sedative
opiate - a narcotic drug that contains opium or an opium derivative
Translations
morfium
morfin
morfiini
morfij
モルヒネ
모르핀
morfin
มอร์ฟีน
moóc phin

morphine

[ˈmɔːrfiːn] nmorphine f

morphine

nMorphium nt, → Morphin nt (spec)

morphine

[ˈmɔːfiːn] morphia [ˈmɔːfɪə] nmorfina

morphine

مُورِفِيـن morfium morfin Morphium μορφίνη morfina morfiini morphine morfij morfina モルヒネ 모르핀 morfine morfin morfina morfina морфий morfin มอร์ฟีน morfin moóc phin 吗啡

mor·phine

n. morfina, alcaloide que se obtiene del opio y se usa como analgésico y sedante.

morphine

n morfina
References in periodicals archive ?
Currently available opioids with ADF labeling include OxyContin (oxycodone HC1), newly formulated in 2010; Targiniq ER (oxycodone HC1 with naloxone); Embeda (morphine with naltrexone), newly labeled in 2014; Hyslingla ER (hydrocodone); Morphabond (morphine); Xtampza ER (oxycodone); Troxyca ER (oxycodone HC1 with naltrexone; Arymo ER (morphine); Vantrela ER (hydrocodone); and Roxybond (oxycodone IR).
COMMON OPIODS Generic Brand Name Hydrocodone Vicodin, Lorcet, Lortab, Norco Zohydro Oxycodone Percocet,OxyContin, Roxicodone Percodan Morphine MSContin, Kadian, Embeda Avinza Codeine Tyeo, Tylenol #3 Fentanyl Duragesic Hydromorphone Dilaudid Oxymorphone Opana Meperidine Demerol Methadone Dolophine,Methadose Signs of an opioid overdose include Slow or shallow breathing, blue or gray lips and fingernails, pale and/or clammy skin, unable to wake up or respond.
s Embeda can have labeling indicating that it has properties expected to reduce abuse of the drug when it is crushed and taken orally or snorted.
Food and Drug Administration today approved new labeling for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release (ER) capsules, an opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
M2 PHARMA-November 5, 2013-Pfizer Inc awarded FDA approval for Prior Approval Supplement for EMBEDA for the management of moderate to severe pain(C)2013 M2 COMMUNICATIONS
M2 EQUITYBITES-November 5, 2013-Pfizer Inc awarded FDA approval for Prior Approval Supplement for EMBEDA for the management of moderate to severe pain(C)2013 M2 COMMUNICATIONS http://www.
Method number five (sequestered API antagonist) is found in Embeda, a product of King Pharmaceuticals, which was acquired by Pfizer in 2010.
Since the launch of the first abuse-resistant product, Embeda, in 2009, a whole range of novel products and reformulations of existing product ranges have been brought to the market.
Enteric Coated (Canada) Morphine sulfate Kadian Actavis Kadian; Alpharma Branded Products Morphine Sulfate Actavis Elizabeth LLC Extended Release Capsules Morphine Embeda King sulfate/naltrexone Pharmaceuticals/Actavis Pancrelipase Cotazym ECS (OTC in Organon Canada Canada) Ltd.
Then, in August 2009, the FDA approved Embeda, a long-acting opioid, for moderate to severe pain.
Opioids included in the REMS plan include methadone (Dolophine), the morphine formulations MS Contin, Kadian, Avinza, Embeda, Oramorph, oxycodone (OxyContin), hydromorphone (Exalgo), transdermal fentanyl (Duragesic), buprenorphine (Butrans), and oxymor-phone (Opana ER).
Opioids included in the REMS plan include methadone (Dolophine), and the morphine formulations MS Contin, Kadian, Avinza, Embeda, Oramorph, oxycodone (OxyContin), hydromorphone (Exalgo), transdermal fentanyl (Duragesic), buprenorphine (Bu-trans), and oxymorphone (Opana ER).